Paramount BioCapital Asset Management paramountbio.com

Paramount BioCapital is a pharmaceutical development and healthcare investment firm.

Paramount BioCapital is a pharmaceutical development and healthcare investment firm.

See All Exits Recent Exits

787 Seventh Avenue
48th Floor
New York, 10019
New York, United States

Paramount BioCapital Asset Management - Investments & Acquisitions

See all Recent Investments

Date	Company	Round	Amount	Co-investors
2011-04-06	Tracon Pharmaceuticals	Series A	$14M	Arcus Ventures, Brookline Investments, JAFCO Co., Nextech Venture, and Undisclosed Venture Investors
2011-02-11	Cascadian Therapeutics	PIPE	$0.15M	Atoll Asset Management, AXA, Bristol Capital Advisors, Cantara, Cowen Group, Dafna Capital Management, Deerfield Management, Downsview Capital, Evolution Capital Management, Global Capital Partners, Heights Capital Management, Highbridge Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, JGB Management, RG Capital Management, Rockmore Capital, Tail Wind Fund, and Undisclosed Venture Investors
2007-07-19	Antares Pharma	Unattributed VC - V	$16M	Centrecourt, Enable Capital Management, Fort Mason Capital, George Weiss Associates, Heights Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, Perceptive Advisors, UBS, Whalehaven Capital, and William Harris Investors
2007-06-14	BioSante Pharmaceuticals	Unattributed VC - III	$18.33M	Bristol Capital Advisors, Cantara, Cowen Group, Diamond Asset Management Llc, Downsview Capital, Excellence Nessuah Mutual Funds Management, Fort Mason Capital, Global Capital Partners, Hudson Bay Capital Management, Ion Asset Management, Iroquois Capital Group, Menora Mivtachim Insurance, Rockmore Capital, Sheffield Asset Management Company, Tao Tsuot, Venture Group, and Y.A.Z. Investments & Assets
2007-05-23	Canyon Resources	Unattributed VC - III	$4.95M	Cantara, Hedgehog Capital, Heller Capital Partners, Iroquois Capital Group, and Milfam

See all 5 investments